[Can the association of an atropinic (SCH 1000) and a sympathicomimetic improve the bronchodilatation obtained by a sympathicomimetic alone (author's transl)].
D001249:Asthma / Q000188:drug therapy*; D001285:Atropine / Q000627:therapeutic use*; D001286:Atropine Derivatives; D001991:Bronchitis / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D004983:Ethanolamines / Q000627:therapeutic use*; D005280:Fenoterol / Q000627:therapeutic use*; D006801:Humans; D009241:Ipratropium / Q000627:therapeutic use*; D012129:Respiratory Function Tests; D013566:Sympathomimetics / Q000627:therapeutic use
D001286:Atropine Derivatives; D001993:Bronchodilator Agents; D004983:Ethanolamines; D013566:Sympathomimetics; D005280:Fenoterol; D001285:Atropine; D009241:Ipratropium
L'association d'un atropinique (SCH 1000) et d'une substance sympathicomimétique peut-elle améliorer la bronchodilatation obenue par un sympathicomimétique seul